The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2

Pharmacol Res. 2020 Oct:160:105073. doi: 10.1016/j.phrs.2020.105073. Epub 2020 Jul 9.

¹ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, PR China.
² Dongguan People's Hospital, Dongguan, 523059, PR China.
³ Dongguan People's Hospital, Dongguan, 523059, PR China. Electronic address: cailihua0912@163.com.
⁴ Dongguan People's Hospital, Dongguan, 523059, PR China. Electronic address: shenlihan@hotmail.com.
⁵ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau; KingMed Virology Diagnostic & Translational Center, PR China. Electronic address: jeffyah@163.com.

No abstract available

Publication types